Screener
EBIT at other companies
Other financials
Where this comes from
Calculated from Bristol-Myers Squibb’s reported figures.
The source filing: Bristol-Myers Squibb’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 11:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0000014272-26-000020
FAQ
- What is Bristol-Myers Squibb's EBIT?
- Bristol-Myers Squibb (BMY) reported EBIT of $4.09B in Q2 2026.
- How has Bristol-Myers Squibb's EBIT changed year-over-year?
- Bristol-Myers Squibb's EBIT increased by 130.5% year-over-year, from $1.77B to $4.09B.
- What is the long-term trend for Bristol-Myers Squibb's EBIT?
- Over 4 years (2021 to 2025), Bristol-Myers Squibb's EBIT has grown at a 3.6% compound annual growth rate (CAGR), from $8.1B to $9.33B.
- What does EBIT mean?
- Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.
Ask your AI about Bristol-Myers Squibb's ebit.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude